| Product Code: ETC10765582 | Publication Date: Apr 2025 | Updated Date: Feb 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
Canada`s import trend for the pemetrexed market exhibited a decline in growth rate from 2023 to 2024, with a recorded decrease of -13.13%. Despite this, the compound annual growth rate (CAGR) for the period 2020-2024 stood at 1.13%. This shift in import momentum could be attributed to fluctuations in demand or changes in market dynamics, highlighting the need for strategic market analysis and adaptive trade strategies.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Canada Pemetrexed Market Overview |
3.1 Canada Country Macro Economic Indicators |
3.2 Canada Pemetrexed Market Revenues & Volume, 2022 & 2032F |
3.3 Canada Pemetrexed Market - Industry Life Cycle |
3.4 Canada Pemetrexed Market - Porter's Five Forces |
3.5 Canada Pemetrexed Market Revenues & Volume Share, By Indication, 2022 & 2032F |
3.6 Canada Pemetrexed Market Revenues & Volume Share, By Mechanism of Action, 2022 & 2032F |
3.7 Canada Pemetrexed Market Revenues & Volume Share, By Combination Therapy, 2022 & 2032F |
3.8 Canada Pemetrexed Market Revenues & Volume Share, By End User, 2022 & 2032F |
3.9 Canada Pemetrexed Market Revenues & Volume Share, By Administration Route, 2022 & 2032F |
4 Canada Pemetrexed Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of lung cancer in Canada |
4.2.2 Growing adoption of pemetrexed as a first-line treatment for non-small cell lung cancer |
4.2.3 Government initiatives and funding to improve cancer care and access to advanced treatments |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval process for new cancer drugs in Canada |
4.3.2 High cost associated with pemetrexed treatment |
4.3.3 Limited awareness and education among healthcare professionals and patients about the benefits of pemetrexed therapy |
5 Canada Pemetrexed Market Trends |
6 Canada Pemetrexed Market, By Types |
6.1 Canada Pemetrexed Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Canada Pemetrexed Market Revenues & Volume, By Indication, 2022 - 2032F |
6.1.3 Canada Pemetrexed Market Revenues & Volume, By Non-Small Cell Lung Cancer, 2022 - 2032F |
6.1.4 Canada Pemetrexed Market Revenues & Volume, By Mesothelioma, 2022 - 2032F |
6.1.5 Canada Pemetrexed Market Revenues & Volume, By Breast Cancer, 2022 - 2032F |
6.1.6 Canada Pemetrexed Market Revenues & Volume, By Colorectal Cancer, 2022 - 2032F |
6.1.7 Canada Pemetrexed Market Revenues & Volume, By Pancreatic Cancer, 2022 - 2032F |
6.2 Canada Pemetrexed Market, By Mechanism of Action |
6.2.1 Overview and Analysis |
6.2.2 Canada Pemetrexed Market Revenues & Volume, By Antifolate, 2022 - 2032F |
6.2.3 Canada Pemetrexed Market Revenues & Volume, By DNA Synthesis Inhibition, 2022 - 2032F |
6.2.4 Canada Pemetrexed Market Revenues & Volume, By Enzyme Targeting, 2022 - 2032F |
6.2.5 Canada Pemetrexed Market Revenues & Volume, By Cell Growth Suppression, 2022 - 2032F |
6.2.6 Canada Pemetrexed Market Revenues & Volume, By Purine Synthesis Blockade, 2022 - 2032F |
6.3 Canada Pemetrexed Market, By Combination Therapy |
6.3.1 Overview and Analysis |
6.3.2 Canada Pemetrexed Market Revenues & Volume, By Platinum-Based Chemotherapy, 2022 - 2032F |
6.3.3 Canada Pemetrexed Market Revenues & Volume, By Immunotherapy, 2022 - 2032F |
6.3.4 Canada Pemetrexed Market Revenues & Volume, By Radiation Therapy, 2022 - 2032F |
6.3.5 Canada Pemetrexed Market Revenues & Volume, By Personalized Medicine, 2022 - 2032F |
6.3.6 Canada Pemetrexed Market Revenues & Volume, By Monoclonal Antibodies, 2022 - 2032F |
6.4 Canada Pemetrexed Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Canada Pemetrexed Market Revenues & Volume, By Hospitals, 2022 - 2032F |
6.4.3 Canada Pemetrexed Market Revenues & Volume, By Oncology Clinics, 2022 - 2032F |
6.4.4 Canada Pemetrexed Market Revenues & Volume, By Specialty Clinics, 2022 - 2032F |
6.4.5 Canada Pemetrexed Market Revenues & Volume, By Research Institutes, 2022 - 2032F |
6.4.6 Canada Pemetrexed Market Revenues & Volume, By Pharmaceutical Companies, 2022 - 2032F |
6.5 Canada Pemetrexed Market, By Administration Route |
6.5.1 Overview and Analysis |
6.5.2 Canada Pemetrexed Market Revenues & Volume, By Intravenous, 2022 - 2032F |
6.5.3 Canada Pemetrexed Market Revenues & Volume, By Injection, 2022 - 2032F |
6.5.4 Canada Pemetrexed Market Revenues & Volume, By IV Infusion, 2022 - 2032F |
6.5.5 Canada Pemetrexed Market Revenues & Volume, By Cancer Treatment Centers, 2022 - 2032F |
6.5.6 Canada Pemetrexed Market Revenues & Volume, By Hospital Pharmacy, 2022 - 2032F |
7 Canada Pemetrexed Market Import-Export Trade Statistics |
7.1 Canada Pemetrexed Market Export to Major Countries |
7.2 Canada Pemetrexed Market Imports from Major Countries |
8 Canada Pemetrexed Market Key Performance Indicators |
8.1 Patient survival rates post pemetrexed treatment |
8.2 Rate of adoption of pemetrexed in lung cancer treatment protocols |
8.3 Number of clinical trials and research studies on pemetrexed efficacy and safety |
8.4 Patient satisfaction and quality of life improvements after receiving pemetrexed therapy |
8.5 Percentage of healthcare facilities offering pemetrexed treatment as part of their standard care protocols |
9 Canada Pemetrexed Market - Opportunity Assessment |
9.1 Canada Pemetrexed Market Opportunity Assessment, By Indication, 2022 & 2032F |
9.2 Canada Pemetrexed Market Opportunity Assessment, By Mechanism of Action, 2022 & 2032F |
9.3 Canada Pemetrexed Market Opportunity Assessment, By Combination Therapy, 2022 & 2032F |
9.4 Canada Pemetrexed Market Opportunity Assessment, By End User, 2022 & 2032F |
9.5 Canada Pemetrexed Market Opportunity Assessment, By Administration Route, 2022 & 2032F |
10 Canada Pemetrexed Market - Competitive Landscape |
10.1 Canada Pemetrexed Market Revenue Share, By Companies, 2025 |
10.2 Canada Pemetrexed Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here